Redesign Science
New York
About Redesign Science
Redesign Science is a computational chemistry company setting a new standard for early-stage, small molecule drug discovery. They efficiently simulate protein targets at the atomic level to reveal hidden, subtle drug opportunities that fall outside the capability and scope of alternative computational models.Basic science is proliferating with new understanding of biological pathways and disease mechanisms. New technologies are needed to solve emerging challenges and to commercialize new opportunities.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $17.0M
- Funding stage: Seed
- Last round: Seed (Dec 2021)
- Website: redesignscience.com
Industries & Categories
Biotechnology, Health Care, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/redesign-science-94958 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.